Icade (ICAD.PA) fair value

ACCE thesis

Icade is a Paris-listed REIT that owns and develops offices, healthcare facilities (clinics and care homes) and urban logistics assets, with a development arm that builds for third parties and for its own portfolio. At a forward P/E of 5.1 and an operating margin of 16.5%, the market is pricing the equity as if the asset base is worth far less than the cash it throws off, and the negative ROE of -5.2% shows that accounting earnings have not kept pace with that cash. Revenue fell 3.0%, so the bull case rests on the healthcare and logistics mix offsetting weakness in the office book rather than on any near-term top-line recovery. The question for a deeper look is whether the discount reflects impairment risk and refinancing pressure on the office portfolio, or whether the market is simply underweighting a defensive healthcare exposure. The data here cannot settle that, so the next step is the asset valuations and debt maturity schedule.